Aptus Pharma Limited (BOM:544529)

India · Delayed Price · Currency is INR

228.90

+4.15 (1.85%)

At close: Jun 23, 2026

608.23% (1Y)

Market Cap	4.00B
Revenue (ttm)	465.75M +160.8%
Net Income	46.20M +437.3%
EPS	3.11 +35.7%
Shares Out	17.15M
PE Ratio	75.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,800
Open	229.20
Previous Close	224.75
Day's Range	225.85 - 229.20
52-Week Range	32.32 - 238.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 24, 2026

About Aptus Pharma

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) fo... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 2010

Employees 70

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544529

Full Company Profile

Financial Performance

In fiscal year 2026, Aptus Pharma's revenue was 465.75 million, an increase of 89.65% compared to the previous year's 245.58 million. Earnings were 46.20 million, an increase of 49.05%.

Financial Statements